Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Incidental thyroid cancer detected by (18)F-FDG PET: does it have different clinicopathological features?

Pak K, Cheon GJ, Lee KE, Park YJ, Choi HS, Min HS, Kang KW, Chung JK, Kim EE, Lee DS.

Nucl Med Commun. 2014 May;35(5):453-8. doi: 10.1097/MNM.0000000000000076.

PMID:
24419499
2.

Incidental thyroid carcinoma by FDG-PET/CT: a study of clinicopathological characteristics.

Law TT, Lang BH.

Ann Surg Oncol. 2011 Feb;18(2):472-8. doi: 10.1245/s10434-010-1287-6. Epub 2010 Aug 26.

3.

The significance and management of incidental [18F]fluorodeoxyglucose-positron-emission tomography uptake in the thyroid gland in patients with cancer.

Eloy JA, Brett EM, Fatterpekar GM, Kostakoglu L, Som PM, Desai SC, Genden EM.

AJNR Am J Neuroradiol. 2009 Aug;30(7):1431-4. doi: 10.3174/ajnr.A1559. Epub 2009 Apr 2.

4.

Incidental ¹⁸F-FDG uptake in the thyroid in patients diagnosed with PET/CT for other malignancies.

Czepczyński R, Stangierski A, Oleksa R, Janicka-Jedyńska M, Czarnywojtek A, Ruchała M, Sowiński J.

Nucl Med Rev Cent East Eur. 2011;14(2):68-72.

5.

Incidental thyroid "PETomas": clinical significance and novel description of the self-resolving variant of focal FDG-PET thyroid uptake.

Nishimori H, Tabah R, Hickeson M, How J.

Can J Surg. 2011 Apr;54(2):83-8. doi: 10.1503/cjs.023209.

6.
7.

Focal thyroid incidental uptake detected by ¹⁸F-fluorodeoxyglucose positron emission tomography. Meta-analysis on prevalence and malignancy risk.

Treglia G, Bertagna F, Sadeghi R, Verburg FA, Ceriani L, Giovanella L.

Nuklearmedizin. 2013;52(4):130-6. doi: 10.3413/Nukmed-0568-13-03. Epub 2013 Jun 14.

PMID:
23765102
8.

A risk-adapted approach using US features and FNA results in the management of thyroid incidentalomas identified by 18F-FDG PET.

Choi JS, Choi Y, Kim EK, Yoon JH, Youk JH, Han KH, Moon HJ, Kang WJ, Kwak JY.

Ultraschall Med. 2014 Feb;35(1):51-8. doi: 10.1055/s-0033-1335328. Epub 2014 Jan 23.

PMID:
24458573
9.

Histological aggressiveness of fluorodeoxyglucose positron-emission tomogram (FDG-PET)-detected incidental thyroid carcinomas.

Are C, Hsu JF, Ghossein RA, Schoder H, Shah JP, Shaha AR.

Ann Surg Oncol. 2007 Nov;14(11):3210-5. Epub 2007 Aug 23.

PMID:
17713821
10.

High incidence of thyroid cancer in focal thyroid incidentaloma detected by 18F-fluorodeoxyglucose [corrected] positron emission tomography in relatively young healthy subjects: results of 3-year follow-up.

Ohba K, Nishizawa S, Matsushita A, Inubushi M, Nagayama K, Iwaki H, Matsunaga H, Suzuki S, Sasaki S, Oki Y, Okada H, Nakamura H.

Endocr J. 2010;57(5):395-401. Epub 2010 Feb 17. Erratum in: Endocr J. 2011;58(6):517.

11.
12.

Thyroid incidentaloma identified by ¹⁸F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance.

Pagano L, Samà MT, Morani F, Prodam F, Rudoni M, Boldorini R, Valente G, Marzullo P, Baldelli R, Appetecchia M, Isidoro C, Aimaretti G.

Clin Endocrinol (Oxf). 2011 Oct;75(4):528-34. doi: 10.1111/j.1365-2265.2011.04107.x.

PMID:
21575027
13.

Thyroid incidentaloma detected by fluorodeoxyglucose positron emission tomography/computed tomography: practical management algorithm.

Nilsson IL, Arnberg F, Zedenius J, Sundin A.

World J Surg. 2011 Dec;35(12):2691-7. doi: 10.1007/s00268-011-1291-4.

PMID:
21989645
14.

Thyroid incidentalomas on FDG PET/CT in patients with non-thyroid cancer - a large retrospective monocentric study.

Kim H, Kim SJ, Kim IJ, Kim K.

Onkologie. 2013;36(5):260-4. doi: 10.1159/000350305. Epub 2013 Apr 15.

PMID:
23689220
15.

FDG-PET detected thyroid incidentalomas: need for further investigation?

Are C, Hsu JF, Schoder H, Shah JP, Larson SM, Shaha AR.

Ann Surg Oncol. 2007 Jan;14(1):239-47. Epub 2006 Oct 6.

PMID:
17024553
16.

Prevalence and risk of cancer of thyroid incidentaloma identified by fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.

Yang Z, Shi W, Zhu B, Hu S, Zhang Y, Wang M, Zhang J, Yao Z, Zhang Y.

J Otolaryngol Head Neck Surg. 2012 Oct;41(5):327-33.

PMID:
23092835
17.

Effect of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography-guided management of suspected recurrent papillary thyroid carcinoma: long-term follow-up with tumour marker responses.

Dennis K, Hay JH, Wilson DC.

Clin Oncol (R Coll Radiol). 2012 Dec;24(10):e168-72. doi: 10.1016/j.clon.2012.08.002. Epub 2012 Sep 1.

PMID:
22944464
18.

Evaluation of thyroid FDG uptake incidentally identified on FDG-PET/CT imaging.

Chen W, Parsons M, Torigian DA, Zhuang H, Alavi A.

Nucl Med Commun. 2009 Mar;30(3):240-4. doi: 10.1097/MNM.0b013e328324b431.

PMID:
19262287
19.

Focal thyroid incidentalomas identified with whole-body FDG-PET warrant further investigation.

Prichard RS, Cotter M, Evoy D, Gibbons D, Collins C, McDermott E, Skehan S.

Ir Med J. 2011 Jun;104(6):177-9.

PMID:
22111394
20.

Thyroid incidentalomas on fluorine-18-fluorodeoxyglucose positron emission tomography-computed tomography: incidence, malignancy risk, and comparison of standardized uptake values.

Kao YH, Lim SS, Ong SC, Padhy AK.

Can Assoc Radiol J. 2012 Nov;63(4):289-93. doi: 10.1016/j.carj.2011.04.003. Epub 2011 Dec 3.

PMID:
22136969
Items per page

Supplemental Content

Write to the Help Desk